In the progression of renal fibrosis, ROS can promote hypermethylation of the NDRG2 promoter [62], which is consistent with findings in diabetic retinopathy, where inhibiting DNMT1 was shown to reduce ROS levels [63]. Here, DNMT1 is linked to renal fibrosis.